NCT07112222View on ClinicalTrials.gov

A Study of LM-350 in Subjects With Advanced Solid Tumours

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2030

Conditions
Malignant Tumors
Interventions
DRUG

LM-350 for injection

Q3W,Intravenous Drip

Trial Locations (1)

Unknown

Peninsula and South Eastern Haematology and Oncology Group, Frankston

Sponsors
All Listed Sponsors
lead

LaNova Medicines Limited

INDUSTRY